Home » EU/U.S. GMP Inspections Strategy Could Spell Relief for Drugmakers
EU/U.S. GMP Inspections Strategy Could Spell Relief for Drugmakers
The European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) plan to step up cooperation on good manufacturing practice (GMP) inspections, moving from information-sharing and joint inspections to outright reliance on one another’s results.
International Pharmaceutical Regulatory Monitor
International Pharmaceutical Regulatory Monitor
Upcoming Events
-
07May
-
14May
-
30May